NASSER HANNA

297 KENT ST, Maryborough, Queensland, Australia

Also known as:

nr hanna

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

25.0%

Trial Status Distribution

Active, not recruiting

25.0%

Completed

50.0%

Terminated

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

Phase 2

Active, not recruiting

interventional

May 2020100 participants

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Phase 2

Terminated

interventional

Nov 201830 participants

Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse

Completed

observational

Nov 20156 participants

Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors

Phase 1

Completed

interventional

Apr 201514 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations